Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Fusion protein or fusion polypeptide
Patent
1995-04-10
1998-08-11
Walsh, Stephen
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Fusion protein or fusion polypeptide
530397, 530398, 4241981, 435 697, 930110, C07K 1459, A61K 3824
Patent
active
057924600
ABSTRACT:
"Partial" and "complete" CTP units are used to modify biologically active proteins and peptides to alter their clearance patterns. "Complete" CTP units have the amino acid sequence found at positions 112-118 to position 145 of the .beta.-subunit of human chorionic gonadotropin; "partial" CTP units are missing at least one amino acid in the region of position 118-145 inclusive. Variants of these CTP units contain 1-5 conservative amino acid substitutions which do not destroy activity. Suitable peptides or proteins which may be modified in this manner include various hormones and cytokines.
REFERENCES:
patent: 4654324 (1987-03-01), Chance et al.
patent: 4959455 (1990-09-01), Clark et al.
patent: 5177193 (1993-01-01), Boime et al.
patent: 5216126 (1993-06-01), Cox et al.
patent: 5217881 (1993-06-01), Park
patent: 5338835 (1994-08-01), Boime
CF Goochee et al. Bio/Technology 9:1347 Dec. 1991.
CG Davis et al. J. Biol Chem 261(6):2828 Feb. 25, 1986.
MJ Kessler et al. J. BiolChem 254(16):7909 Aug. 25, 1979.
Huston, J.S. et al., "Protein engineering of antibody binding sites: Recovery of specific activity in an anti-digoxin single-chain Fv analogue produced in Escherichia coli," Proc. Natl. Acad. Sci. USA (Aug. 1988) 85:5879-5883.
Chen, W. et al., "Polyclonal antibodies against the polypeptide and carbohydrate epitopes of recombinant human choriogonadotropin .beta.-subunit," Molecular and Cellular Endocrinology (1992) 86:57-66.
Boime, I. et al. "Structure-function studies of gonadotropins using site-directed mutagenesis and gene transfer: design of a long-acting follitropin agonist," Chemical Abstracts 123(1):347-356.
LaPolt, P.S. et al.; Enhanced Stimulation of Follicle Maturation and Ovulatory Potential by Long Acting Follicle-Stimulating Hormone Agonists wtih Extended Carboxyl-Terminal Peptides; Endocrinology (1992) 131:2514-2520.
Fares, F.A. et al.; Design of a Long-acting Follitropin Agonist by Fusing the C-terminal Sequence of the Chorionic Gonadotropin .beta. Subunit to the Follitropin .beta. Subunit Proc Natl Acad Sci USA (1992) 89:4304-4308.
Spector S.
Walsh Stephen
Washington University
LandOfFree
Modified glycoprotein hormones having a CTP at the amino terminu does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Modified glycoprotein hormones having a CTP at the amino terminu, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Modified glycoprotein hormones having a CTP at the amino terminu will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-386500